← Eichor
Study identifier: NCT05536388 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Drug Discovery for Parkinson's With Mutations in the GBA Gene

Condition: Parkinson Disease · Gaucher Disease · Healthy  ·  Sponsor: New York Stem Cell Foundation Research Institute

PhaseN/A
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate Parkinson's disease research and drug development by using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for Parkinson's disease.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Research Office  ·  212-927-1801  ·  clinicalresearch@nyscf.org

Always discuss trial participation with your own doctor first.

Locations (1)

The New York Stem Cell Foundation Research InstituteNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05536388